Results 151 to 160 of about 36,270 (222)

THE POLYSACCHARIDE OF SHIGELLA FLEXNERI, TYPE 3

Journal of Biological Chemistry, 1953
M W, SLEIN, G W, SCHNELL
openaire   +2 more sources

Multidrug-resistant Shigella flexneri outbreak affecting humans and non-human primates in New Mexico, USA. [PDF]

Nat Commun
Shrum Davis S, Salazar-Hamm P, Edge K, Hanosh T, Houston J, Griego-Fisher A, Lugo F, Wenzel N, Malone D, Bradford C, Plymesser K, Baker M, Schwalm K, Lathrop S, Smelser C, Dinwiddie DL, Domman D.   +16 more
europepmc   +1 more source

An Outbreak of Multidrug-Resistant <i>Shigella flexneri</i> Serotype 2a Among People Experiencing Homelessness in Vancouver. [PDF]

Trop Med Infect Dis
Leung V, Ritchie G, Stefanovic A, Lee C, Chorlton S, Matic N, Romney MG, Hayden A, Lowe CF.   +8 more
europepmc   +1 more source

Keresztvédelmet biztosító Shigella vakcina jelöltek karakterizálása [PDF]

, 2014
Szijártó Valéria
core  

Gut commensal <i>Bifidobacterium longum</i> confers resistance to <i>Salmonella</i> Typhimurium and <i>Shigella flexneri</i> in a <i>Caenorhabditis elegans</i> model. [PDF]

Microbiol Spectr
Harnvoravongchai P, Mattiello SP, Amabat A, C P J, Faisal SM, Kaushik RS, Scaria J.   +6 more
europepmc   +1 more source

Genomic characterization of azithromycin-resistant and extended-spectrum β-lactamase-producing <i>Shigella flexneri</i> 2a from two clinical isolates in Japan. [PDF]

JAC Antimicrob Resist
Kobayashi Y, Umeda S, Takahashi K, Shibata S, Shibayama K, Suzuki M.   +5 more
europepmc   +1 more source

Isolation, characterization, therapeutic and prophylactic applications of a lytic bacteriophage to combat multi-drug resistance Shigella flexneri: an animal study model. [PDF]

GMS Hyg Infect Control
Abbasi Fashami P, Pournajaf A, Amirmozafari N, Hallajzadeh M, Mahabadi VP, Saghiri R, Khafri S, Golmoradi Zadeh R, Akrami S, Asgharzadeh S, Rajabnia M.   +10 more
europepmc   +1 more source

Outer membrane protein C (OMPC) epitope of <i>Shigella flexneri</i> 3a as a potential marker of primary immunodeficiencies (PID) and isolated anti-OmpC antibodies as a tool for immunoglobulin replacement therapy. [PDF]

Front Immunol
Naporowski P, Witkowska D, Rybka J, Pawlak E, Lewandowicz-Uszyńska A, Masłowska E, Gamian A.   +6 more
europepmc   +1 more source

[Genetics of Shigella flexneri].

Postepy higieny i medycyny doswiadczalnej, 1973
openaire   +1 more source

The Human-Specific miR-6762-5p Is an Activator of RhoA GTPase Enhancing Shigella flexneri Intercellular Spreading. [PDF]

Mol Microbiol
Reisacher C, Saifi E, Ageron E, Mallmann RT, Klugbauer N, Skurnik D, Arbibe L.   +6 more
europepmc   +1 more source